Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 19.91
(1.01%)
CNY 19.91
(1.01%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 706.92 Million CNY | 475.87% |
| 2022 | 122.75 Million CNY | 5050.03% |
| 2021 | 2.38 Million CNY | -76.2% |
| 2020 | 10.01 Million CNY | -49.93% |
| 2019 | 20 Million CNY | -79.7% |
| 2018 | 98.5 Million CNY | -64.7% |
| 2017 | 279 Million CNY | -15.45% |
| 2016 | 330 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 783.35 Million CNY | 10.81% |
| 2024 Q3 | 998.31 Million CNY | 20.06% |
| 2024 Q2 | 831.51 Million CNY | 6.15% |
| 2023 Q3 | 720.67 Million CNY | 188.18% |
| 2023 Q2 | 250.07 Million CNY | 39.08% |
| 2023 Q1 | 179.8 Million CNY | 46.47% |
| 2023 FY | 706.92 Million CNY | 475.87% |
| 2023 Q4 | 706.92 Million CNY | -1.91% |
| 2022 Q4 | 122.75 Million CNY | 81.12% |
| 2022 Q3 | 67.77 Million CNY | 1299.08% |
| 2022 Q2 | 4.84 Million CNY | -2.71% |
| 2022 FY | 122.75 Million CNY | 5050.03% |
| 2022 Q1 | 4.97 Million CNY | 108.91% |
| 2021 Q4 | 2.38 Million CNY | 19.04% |
| 2021 Q3 | 2 Million CNY | 0.0% |
| 2021 Q2 | 2 Million CNY | -98.64% |
| 2021 FY | 2.38 Million CNY | -76.2% |
| 2021 Q1 | 147.3 Million CNY | 1371.06% |
| 2020 FY | 10.01 Million CNY | -49.93% |
| 2020 Q4 | 10.01 Million CNY | -80.58% |
| 2020 Q3 | 51.57 Million CNY | 157.52% |
| 2020 Q2 | 20.02 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q2 | 68.5 Million CNY | 0.0% |
| 2019 FY | 20 Million CNY | -79.7% |
| 2019 Q4 | 20 Million CNY | 0.0% |
| 2018 FY | 98.5 Million CNY | -64.7% |
| 2017 FY | 279 Million CNY | -15.45% |
| 2016 FY | 330 Million CNY | 0.0% |